LY9
Basic information
Region (hg38): 1:160796074-160828483
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LY9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 40 | 45 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 40 | 5 | 2 |
Variants in LY9
This is a list of pathogenic ClinVar variants found in the LY9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-160796226-T-C | Likely benign (Dec 15, 2017) | |||
1-160796285-A-C | not specified | Uncertain significance (Oct 12, 2022) | ||
1-160796301-C-G | not specified | Uncertain significance (Feb 14, 2023) | ||
1-160799779-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
1-160799801-T-C | not specified | Uncertain significance (Jul 21, 2022) | ||
1-160799805-AG-A | association (Aug 30, 2022) | |||
1-160799846-C-T | not specified | Uncertain significance (Oct 05, 2022) | ||
1-160799897-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
1-160799899-C-T | not specified | Uncertain significance (Feb 05, 2024) | ||
1-160799900-G-A | LY9-related disorder | Likely benign (Jan 10, 2024) | ||
1-160799910-A-C | not specified | Uncertain significance (Nov 04, 2023) | ||
1-160799918-C-A | not specified | Uncertain significance (Nov 09, 2023) | ||
1-160799978-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
1-160813645-A-G | not specified | Uncertain significance (Feb 07, 2023) | ||
1-160813712-G-A | not specified | Uncertain significance (Mar 16, 2022) | ||
1-160813716-T-G | not specified | Uncertain significance (Jul 25, 2023) | ||
1-160813725-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
1-160813738-G-C | not specified | Uncertain significance (Oct 31, 2022) | ||
1-160813767-C-A | Benign (Dec 15, 2017) | |||
1-160813813-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
1-160813863-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
1-160813888-T-C | not specified | Uncertain significance (Jun 29, 2023) | ||
1-160814461-G-T | not specified | Uncertain significance (Feb 10, 2022) | ||
1-160814513-G-A | not specified | Likely benign (Jul 09, 2021) | ||
1-160814530-G-A | not specified | Uncertain significance (Nov 18, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LY9 | protein_coding | protein_coding | ENST00000263285 | 10 | 32188 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.60e-13 | 0.240 | 125723 | 0 | 12 | 125735 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.217 | 368 | 356 | 1.03 | 0.0000183 | 4256 |
Missense in Polyphen | 83 | 90.545 | 0.91667 | 1201 | ||
Synonymous | 0.800 | 134 | 146 | 0.916 | 0.00000828 | 1331 |
Loss of Function | 1.08 | 23 | 29.3 | 0.785 | 0.00000162 | 319 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000250 | 0.000244 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000372 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000657 | 0.0000653 |
Other | 0.000166 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. May participate in adhesion reactions between T lymphocytes and accessory cells by homophilic interaction. Promotes T-cell differentiation into a helper T-cell Th17 phenotype leading to increased IL-17 secretion; the costimulatory activity requires SH2D1A (PubMed:22184727). Promotes recruitment of RORC to the IL-17 promoter (PubMed:22989874). May be involved in the maintenance of peripheral cell tolerance by serving as a negative regulator of the immune response. May disable autoantibody responses and inhibit IFN-gamma secretion by CD4(+) T-cells. May negatively regulate the size of thymic innate CD8(+) T-cells and the development of invariant natural killer T (iNKT) cells (By similarity). {ECO:0000250|UniProtKB:Q01965, ECO:0000269|PubMed:22184727, ECO:0000269|PubMed:22989874}.;
- Pathway
- TCR
(Consensus)
Intolerance Scores
- loftool
- 0.966
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 62.14
Haploinsufficiency Scores
- pHI
- 0.0472
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.440
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.633
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ly9
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- cell adhesion;positive regulation of interleukin-17 production;innate immune response;T-helper 17 cell lineage commitment
- Cellular component
- plasma membrane;cell surface;integral component of membrane
- Molecular function
- molecular_function